Allarta is a life science start-up with a novel delivery platform of immune-privileged materials, that enable cell and stem cell therapies for the treatment of diabetes and other endocrine disorders.

With pre-seed funding from McMaster University and investors Mark Krembil and Ian Delaney, the SOPHIE collaboration will now enable further pre-clinical studies, paving Allarta’s path to the clinic and it’s goal of treating patients.

Built on 30+ years of foundational expertise, Allarta’s proprietary platform is designed to overcome immune rejection, prevent cell escape and safely deliver cell and stem cell therapies.

Allarta Life Science was co-founded in 2019 by Dr. Harald Stover, one of the world’s leading researchers in polymers and polymer hydrogels, and Maria Antonakos.

Allarta has built a diverse team of scientists and leaders as well as an unparalleled network of researchers, clinicians, academics and entrepreneurs.